Despite the fact that car crashes are the leading cause of death for children older than three years in the U.S. and send more than 140,000 children to the emergency room each year, new research has found that low proportions of U.S. children are using age-appropriate safety restraints and many are placed at risk by riding in the front seat. The research is published in the September issue of the American Journal of Preventive Medicine.
The American Academy of Pediatrics issued new Guidelines for Child Passenger Safety in 2011. They called for rear-facing car seats at least until the age of two; forward-facing car seats with a five-point harness for as long as possible until the child is the maximum weight and height suggested by the manufacturer; booster seats until an adult seat belt fits properly, when a child reaches around 57" in height, the average height of an 11 year old; and riding in the back seat until the age of 13. "We found that few children remain rear-facing after age 1, fewer than 2% use a booster seat after age 7, many over age six sit in the front seat," says Michelle L. Macy, MD, MS, co-author of the study along with Gary L. Freed, MD, MPH, both of the Child Health Evaluation and Research Unit, Division of General Pediatrics, C.S. Mott Children's Hospital at the University of Michigan, Ann Arbor.
The investigators evaluated three years of data from the National Highway Traffic Safety Administration (NHTSA) National Survey on the Use of Booster Seats (NSUBS) collected prior to the release of the new guidelines. Trained data collectors observed and recorded drivers with child passengers as they arrived at community sites including gas stations, fast food restaurants, recreation centers, and child care centers. They recorded child restraint type and seat row, adult and child gender, driver restraint use, and vehicle type. Drivers were interviewed to report their own age, the ages of the children they were transporting, child race, and Hispanic ethnicity. Analyses were conducted on data obtained for 21,476 children.
As children aged, a decline in child safety seat use and an increase in being unrestrained were observed. Within each age group, minority children demonstrated lower proportions of age-appropriate restraint use compared with white children. There were persistent differences in the proportions of black and Hispanic children who were unrestrained compared with whites, ranging from a ten-fold difference among infants and toddlers to a twofold difference for older age groups. Among children aged 0-3, the proportions of rear-facing car seat use were lowest among minority groups, but even among whites just 17% were rear-facing. Higher proportions of minority children were prematurely transitioned to seat belts.
"The most important finding from this study is that, while age and racial disparities exist, overall few children are using the restraints recommended for their age group, and many children over five are sitting in the front seat," says Dr. Macy. "Our findings demonstrate that not all children have been reached equally by community-based public education campaigns and the passage of child safety seat laws in 48 states. Further development and dissemination of culturally specific programs that have demonstrated success in promoting restraint use among minority children are necessary. Further, the findings may also help in developing strategies to lower the racial and ethnic disparities seen in children experiencing crash-related injuries."
Beverly Lytton | EurekAlert!
Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering